Krajang Talabnin

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Signaling Pathway

Top Venues

Life (Basel, Switzerland)

The Journal of international medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Piyasiri Chueakwon, Peeranat Jatooratthawichot, Krajang Talabnin, James R Ketudat Cairns, Chutima Talabnin
Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway. Life (Basel, Switzerland) 12 (3) (2022)
Juthamas Khiaowichit, Chutima Talabnin, Chavaboon Dechsukhum, Atit Silsirivanit, Krajang Talabnin
Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways. Life (Basel, Switzerland) 12 (2) (2022)
Krajang Talabnin, Chutima Talabnin, Juthamas Khiaowichit, Nuchanard Sutatum, Pundit Asavaritikrai, Sanong Suksaweang, Taweesak Tongtawee, Mayumi Ishihara, Parastoo Azadi, Banchob Sripa
High expression of tissue O-linked glycans is associated with a malignant phenotype of cholangiocarcinoma. The Journal of international medical research 49 (2) (2021)
Krajang Talabnin, Chutima Talabnin, Tadahiro Kumagai, Nuchanard Sutatum, Juthamas Khiaowichit, Chawaboon Dechsukhum, Mayumi Ishihara, Parastoo Azadi, Banchob Sripa
Ganglioside GM2: a potential biomarker for cholangiocarcinoma. The Journal of international medical research 48 (7) (2021)